Farms.com Home   Ag Industry News

2015 US Corn Belt Crop Tour: Nebraska

Sixth state in a 12-state tour

By Diego Flammini, Farms.com

The Farms.com Risk Management team, led by Chief Commodity Strategist Moe Agostino are on a 12-state tour of the US Corn Belt.

During their state visits they meet with local farmers to get an in-depth look at how crop fields are performing and how elements such as weather will impact yield and prices.

Ohio, Indiana, Illinois, Missouri and Kansas had been visited before the team visited Nebraska, the third largest corn producing state in the United States.

Nebraska

Throughout the state visits, a common theme occurs.

“Too much moisture has delayed some of the crops and they’re behind,” Agostino said.

However, if crops in Nebraska do get too dry, the farmers there have an alternative to Mother Nature’s rain – pivots and irrigation.

While visiting a soybean field near Norfolk, Nebraska, Agostino saw a familiar-looking field.

“It looks like a lot of the fields we’ve seen to date,” he said. “Excess moisture is taking its toll on a lot of soybean fields across the Midwest. If this continues it could lead to potential drop in yield.”

Despite some of the weather being seen across the Midwest, farmers are managing to have success in their fields.

“We’ve had some real good balanced rain,” said Richard Travers, a farmer from Hartington, Nebraska. “Inch, inch and-a-half a week. The heat units are kicking in now and the beans are loving it.”

Be sure to follow the 2015 US Corn Belt Crop Tour on Twitter using the hashtag #CornBelt15.

The tour’s next stop will be in South Dakota.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.